Patellar tendon bearing orthosis — Application as adjunctive treatment in healing of lower-limb tissue loss  by Khaira, H.S. et al.
Eur J Vasc Endovasc Surg 16, 485488 (1998) 
Patellar Tendon Bearing Orthosis - Application as Adjunctive Treatment 
in Healing of Lower-limb Tissue Loss 
H. S. Khaira 1, 1". Coddington 2, A. Drew 1, P. N. Roberts ~ and C. H. E. Imray *~ 
~Walsgrave NHS Trust Hospital, Clifford Brzdge Road, Walsgrave, Coventry, CV2 2DX, U.K. and 
2Regional Rehabilitation Unit, Oak Tree Lane, Selly Oak, Birmingham, B29 6JA, U.K. 
Objectives: to assess the efficacy of the pateltar tendon bearing orthosis (PTBO) as adjunctive treatment ofpatients with 
significant lower-limb ischaemm and tissue loss comphcated byneuropathy. 
Design, materials and methods: twelve consecutwe patwnts (14 legs) w#h a varzety of underlymg conditions causing 
extensive lower limb tzssue loss are described. Seven patwnts were dmbetlc Six patients (seven legs) underwent vascular 
reconstruction procedures. 
Chief outcome measures: wound healing and amputation rate. 
Results" eight patients had ulcer healing w~thm 5 months, one at 18 months (patwnt wzth alcohohc neuropathy who 
was poorly compliant with treatment), one stopped using the PTBO at 3 months and was converted toprotective footwear 
w#h heahng, one died of a myocar&aI infarct 1 month after the PTBO was fitted (the ulcer was showing signs of heahng), 
and one has lust had surgery and been fitted with a PTBO. 
Conclusions: early results from thzs anecdotal series are encouraging and a prospectwe study to determine the applicatmn 
of the PTBO in patients w~th neuropathic and neuropathic/~schaemzc tissue loss zs planned. 
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Introduction The patellar tendon bearing orthosis (PTBO) was 
originally designed to support body weight for the 
Lower-limb tissue loss can lead to immobility espe- treatment of the below-knee segment which is struc- 
cially if weight bearing surfaces are affected. Diabetic turally inadequate or causes evere pain. 4 We present 
patients are especially prone to this problem because our early experience using a PTBO device in patients 
of the co-existence of ischaemia nd peripheral neuro- with gross lower-limb tissue loss. 
pathy. 1 Peripheral neuropathy is present in ap- 
proximately 50% of cases. 2
In the U.K. more hospital beds are occupied by Materials and Methods 
diabetic patients with disorders of their feet than by 
patients with all other complications of diabetes corn- Each limb with significant issue loss was assessed as 
bined. 1 It is estimated that in the U.S.A. 1% of patients to whether the aetiology was felt to be primarily 
diagnosed as diabetic each year undergo lower ex- neuropathic, ischaemic or mixed. Appropriate de- 
tremity amputation. Diabetics account for 50-70% of bridement was performed and, where vascular re- 
all non-traumatic amputations? This costs in excess of construction was felt to be necessary, an appropriate 
half a billion dollars each year. 2 reconstruction performed. 
The only way to ensure healing is to remove weight Twelve consecutive patients (14 legs) have been 
bearing and friction from the ulcerated areas. Bed rest treated with a PTBO over a period of 18 months. The 
is the surest way in the short-term, but in the long- group included six men and six women with an age 
term it can be extremely trying for the patient. 1Loss range of 32-82 years. Full details are given in Table 1. 
of mobility is a major problem for these patients. All patients were assessed by a multidisciplinary team 
(vascular surgeon, consultant in rehabilitation medi- 
cine, orthotist and physiotherapist) in the acute phase 
*Please address all correspondence to.C H E Imray, Walsgrave 
NHS Trust Hospital, Chfford Bridge Road, Walsgrave, Coventry, on the ward. Follow-up was in the multidisciplinary 
CV2 2DX, U K Vascular Orthotic Clinic. 
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Fig. 1. A completed PTBO ready for flttmg Note the indentation m Fig. 2. A fitted PTBO The patellar tendon rests on the identatlon 
the upper part for the patellar tendon m the upper component The whole device can be worn under 
normal clothing and adapted shoes 
The PTBO was manufactured for each individual 
patient after discussions betweenthevascular surgeon, In addition to the PTBO, standard treatment re- 
the rehabihtation physician and the orthotist The steps gimens were followed. These involved debridement 
involved in the manufacture and supply of the PTBO and vascular reconstruction if appropriate. Con- 
are outlined below: ventional wound management involved Sorbsan 
(Maersk) dressings and Intrasite (Saud N) gel if neces- 
1 A negative plaster of Paris cast of the limb is made sary for chemical debridement. Early mobilisation was 
along with measurements of both limbs, attempted in each case. 
2 A positive plaster of Paris model of the hmb is The aim of the PTBO was to allow the patient to 
made. weight bear via the patellar tendon, unloading the 
3 Thermoplastic shell components are moulded to the ankle/foot complex. This allowed the patient to too- 
plaster of Paris model and the metal side corn- bllise despite significant issue loss in the foot. 
ponents haped. 
4 The components are assembled and any linings, 
insole or partial foot prosthesis fabricated (Fig. 1) 
5 Trial fitting to the patient o test static and dynamic Results 
alignment (Fig. 2) (Care being taken to avoid direct 
pressure on any graft). The results are summarised m Table 2. All patients 
6 Any necessary adjustments are made and the PTBO who continued with the PTBO had ulcer healing by 5 
completed ready for supply, months. Figure 3 shows typical tissue loss (right foot) 
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Table 1. Details of the patients treated with PTBOs. Table 2. Outcome with PTBO according to underlying disease 
process. 
n D~sease process M/F Age Ad&tlonal treatment 
(years) n Disease process Outcome 
Seven Diabetes melhtus 4M 3F 54-82 Five had vascular Seven Dxabetes melhtus Five healed within 5 months 
bypass urgery (1 one Improving but dmd of 
bilateral) Two had myocardial infarct 
previous one had just had surgery 
contralateral major One Bilateral phlegmasla Healed within 5 months 
amputation Foot One Severe sepsis Stopped w aring PTBO at 3 
debrldement, months 
Bypass urgery Changed to footwear 
included One Peripheral vascular Healed within 4 months 
One femoro-pophteal disease 
Two femoro-dlstal One Alcohohc neuropafl~y Healed within 18 months 
One femoro- One Vascuhtls Healed within 4 months 
pophteat-pedal 
One pophteal-pedal 
One Bilateral phlegmasla F 82 Bilateral foot 
debndement 
One Severe sepsm F 37 Bilateral forefoot 
amputation 18 months  to achieve ulcer heahng due to poor 
One Peripheral vascular M 60 Vascular bypass 
disease (femorodlstal) + compl iance - he only wore the PTBO outdoors;  
amputatton four toes (ii) the pat ient  requir ing amputat ion  fo l lowing severe 
One Alcholom neuropathy M 58 Debndement of ulcer sepsis stopped us ing the PTBO at 3 months  and 
One Vascuhtm F 74 Forefoot amputation changed to footwear; 
(iii) the ulcer of one of the diabetic pat ients was im- 
prov ing  but  the pat ient  died at i month  from a 
m a diabetic patient. The left foot is a lmost healed myocardia l  infarction; and 
after 4.5 months  in a PTBO. The exceptions were: (iv) one of the diabetm pat ients has just undergone  
(i) the pat ient  wi th  alcoholic neuropathy  who took surgery. 
Fig. 3. Typical tissue loss is shown m the right foot of this diabetic patient The left foot is almost healed after wearmg a PTBO for 4 5 
months. The right leg had femoro-pophteo-pedal and the left had a femorodlstal bypass 
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Discussion requiring foot debridement. Mobility, rate of wound 
healing, quality of life during wound healing, and 
A PTBO was first used by McIlmurray and Greenbaum cost-effectiveness will be looked at. 
in 1958 for a high school teacher whose heel had been We feel that this simple technique attempts to ad- 
f 
shot away in World War II. * This allowed unloading dress the neuropathic component of tissue loss which 
of the leg at the below-knee level with concomitant currently is often neglected m diabetic patients. It 
retention of the knee motion. The patient was able to allows for early mobilisation and early discharge. 
maintain full mobility. 
Since this initial description PTBOs have been used 
m a variety of conditions 5 affecting the lower leg Acknowledgements 
including congenital malformations, damage to the 
ankle-foot complex following neuropathy, delayed Much of the early experzence with this technique was obtained by 
union of fractures, arthritis, severe burns 6 and diabetic two of the authors (TC and AD) working m collaboration w~th Prof 
R M. Greenhalgh, Charmg Cross Hospital, London. 
complications. 4 
Demopoulous et al. 5 reported their experience with 
an all plastic PTBO in orthopaedic problems of the 
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